Johnson & Johnson vaccine paused over rare blood clots

The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting. Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said. Johnson & Johnson has paused its EU rollout, which started this week.
Read more...

;